Media Summary: Chris Gibson and Dave Hallett discuss their shared vision for industry-shifting tech-enabled drug discovery, and how their ... TECH TALK - How to use AI methods to predict properties of potential drugs and their effects on hundreds of diseases Watch ... Good morning, everyone! Dylan Jovine here with Behind the Markets and for today's topic—AI in drug discovery. We've been ...
Recursion Ceo On 688m Exscientia - Detailed Analysis & Overview
Chris Gibson and Dave Hallett discuss their shared vision for industry-shifting tech-enabled drug discovery, and how their ... TECH TALK - How to use AI methods to predict properties of potential drugs and their effects on hundreds of diseases Watch ... Good morning, everyone! Dylan Jovine here with Behind the Markets and for today's topic—AI in drug discovery. We've been ... Join our discord to talk more about this and many more filings! Discord Link: Everyone is ... What's the one question we obsess over at During the recent Q2 2025 (L)earnings Call,
As AI spreads across biopharma, what will matter most is not who has the flashiest tools, but who can use them to make better ...
